Crinus Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 2013.
2013 Thane, Maharashtra, India Struck Off
Last Updated:
Access Report
About Crinus Pharmaceuticals Private Limited

Crinus Pharmaceuticals Private Limited, a struck off private limited company, was established on 25 April 2013 in Thane, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74120MH2013PTC242506. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nandini Gopinath Nair (Director), Siya Sanket Patil (Director). Past directors included Gopinath Ramankutty Nair, Sanket Suresh Patil. It is based at 401, Sanghavi Tower, Veer Savarkar Path Charai, Thane West, Thane, Maharashtra, 400601.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120MH2013PTC242506

  • Registration Number

    242506

  • Incorporation Date

    25 April 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 2 Months
Company report

Crinus Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Crinus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Crinus Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nandini Gopinath Nair Director 25 Aug 2018 Current
Siya Sanket Patil Director 25 Aug 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Aug 2018 Past
Pramod Abcsdd Director 25 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Crinus Pharmaceuticals.

Enhance accessibility to Crinus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Crinus Pharmaceuticals revenue growth over time
Crinus Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Crinus Pharmaceuticals?

Unlock access to Crinus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Crinus Pharmaceuticals?

Unlock and access historical data on people associated with Crinus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Crinus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crinus Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Crinus Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Nandini Gopinath Nair was appointed as a Director was appointed as a Director on 25 Aug 2018 & has been associated with this company since 7 years 10 months . was documented.

  • Director Appointment

    The activity Siya Sanket Patil was appointed as a Director was appointed as a Director on 25 Aug 2018 & has been associated with this company since 7 years 10 months . was completed.

  • Company Incorporation

    The activity Crinus Pharmaceuticals Private Limited was registered on 25 Apr 2013 with Roc Mumbai & aged 13 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Crinus Pharmaceuticals Private Limited?

The CIN of Crinus Pharmaceuticals Private Limited is U74120MH2013PTC242506.

Where is Crinus Pharmaceuticals Private Limited headquartered?

Crinus Pharmaceuticals Private Limited is headquartered at 401, Sanghavi Tower, Veer Savarkar Path Charai, Thane West, Thane, Maharashtra, 400601.

When was Crinus Pharmaceuticals Private Limited incorporated?

Crinus Pharmaceuticals Private Limited was incorporated on 25 April 2013.

Who are the current directors of Crinus Pharmaceuticals Private Limited?

The current directors of Crinus Pharmaceuticals Private Limited are

What is the primary industry of Crinus Pharmaceuticals Private Limited?

The primary industry of Crinus Pharmaceuticals Private Limited is Pharma.

Is Crinus Pharmaceuticals Private Limited a listed company?

Crinus Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Crinus Pharmaceuticals Private Limited?

The authorized capital of Crinus Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available